Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 80

Oil THC Cannabinoids Research and Development 80

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Tetrahydrocannabinol (THC) Tetrahydrocannabinol, or THC, is the component of the Cannabis plant that produces psychoactive effects that can range from racing thoughts to paranoia. You can learn more about that here.

Epilepsy 100

Epilepsy Pharmaceutical Cannabinoids THC 100

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

JUNE 20, 2019

The compound responsible for the euphoric, mind-altering effect is tetrahydrocannabinol (THC). Department of Transportation (DOT) drug test includes THC, and its presence at defined levels constitutes a positive drug test. percent THC, they could contain high enough levels of THC to make a drug test positive.

THC 74

THC CBD Oil DEA 74

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of THC per annum for Epilepsy, MS and HIV/Aids sufferers alone. kg of CBD and 163.7

Access 100

Access Medicine Chronic Pain Research and Development 100

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. Although both studies will enroll 25 patients initially, the U.S. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. The US approval of Zogenix’s Fintepla, a potential competitor for GW’s drug, has been delayed but still lo… The European Pharmaceutical Review reports.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Project CBD

FEBRUARY 28, 2023

According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3% THC is the primary psychoactive compound in cannabis.) THC is considered “marijuana” or “cannabis.” Epilepsy Behav. Cannabis sativa with more than 0.3% Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC. CBD for Anxiety. How to Use Cannabis for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

JULY 26, 2023

Eligible patients were granted access to low-THC marijuana oil. Its conversion into low-THC cannabis oil also allowed for treating many diseases. The first batch of authorized pharmaceutical retailers is expected to start selling between late August and early September.

Oil 98

Oil Patients Access THC 98

CannaTech

APRIL 1, 2020

When I was at Pharmacy School at Sydney University, more than 20 years ago, we learned the pharmaceutical and clinical sciences ranging from the design, synthesis, formulation, dispensing and testing of drugs and the clinical and social aspects of pharmacy. Low THC/high CBD cannabis can help with depression.

Supply Chain 98

Supply Chain Chronic Pain Pharmaceutical Patients 98

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 26, 2021

OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced a number of updates regarding its Phase IIb clinical study in Tourette Syndrome using the proprietary cannabinoid-based treatment- SCI-110. About SciSparc (OTCQB: SPRCY): SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. While many jurisdictions are still dilly-dallying on legal THC, CBD is legal and flourishing federally across 47 US states and the District of Columbia.

CBD 96

CBD Cannabinoids THC Extraction 96

LifeCannMD

JUNE 23, 2025

Back in 2014, when the Compassionate Medical Cannabis Act first passed, doctors could only recommend very low-THC products that you couldn’t even smoke. Products that have more THC than CBD (whether they’re pills or drops you put under your tongue) really do help with chronic pain. It’s been quite a journey.

Patients 52

Patients Law Chronic Pain Marijuana 52

Kind Meds (Cannabis Education Blog)

APRIL 29, 2019

This unique strain of low-THC, high-CBD marijuana allowed a little girl to truly experience life for the first time by dramatically reducing her seizures. Medical card in hand, Charlotte’s mother found a strain of medical cannabis with extremely low levels of THC and high levels of the CBD the couple hoped would help Charlotte.

Oil 86

Oil Strains Pharmaceutical Research and Development 86

Cannabis Law Report

AUGUST 20, 2021

SLSG and its Swiss subsidiary, Savim SA , are developing specific proprietary strains of cannabis, with a focus on various areas, but particularly on future medical treatments for a variety of illnesses and diseases, including epilepsy, autism, and the different stages of COVID-19.

Research and Development 116

Research and Development Strains Treatment Epilepsy 116

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. The study examines the effect of the cannabinoid Cannabidivarin, more commonly referred to as CBDV , on irritability and repetitive behaviors in children with autism spectrum disorder.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. GW Pharmaceuticals, PLC. have gone a step further and legalized the recreational use of cannabis. Segment Dashboard.

Recreational 73

Recreational Hemp THC Legalization 73

Canna Care Docs

SEPTEMBER 18, 2020

These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. In 2017 Virginia began implementation of in-state production of THC-A and CBD oils. There can be a total of 5 Pharmaceutical Processors in the state, one for each Health Service area HSA.

Pharmaceutical 98

Pharmaceutical Conditions Oil Patients 98

Cannabis Law Report

JULY 9, 2021

Even though CBD comes from the same plant as tetrahydrocannabinol (THC), it is not a psychoactive compound so therefore it will not create a sensation of feeling ‘high’. Usually, mental health conditions are treated using pharmaceutical drugs, although they can result in side effects such as agitation, drowsiness, headaches, and insomnia.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

CannaMD

JULY 14, 2020

Due to many common pharmaceuticals being tested mainly on younger patients who aren’t dealing with multiple conditions, unforeseen problems often occur when older patients end up being prescribed multiple medications at a time. After beginning to take a mixture of CBD and THC, she was able to come off all of her other medications.

Marijuana 105

Marijuana Conditions Patients Epilepsy 105

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Marijuanally

AUGUST 30, 2018

CBD, unlike THC [the psychoactive cannabinoid], won’t get you high. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. 3% of THC within the plant once fully matured. What is CBD? Products containing less than.3%

Topical 73

Topical Hemp CBD Cannabinoids 73

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Epilepsy Cannabinoids THC 74

Miss Marijuana

JANUARY 31, 2025

THC and CBD work together to relieve nerve pain, helping people feel less discomfort and more in control. Epilepsy and Seizure Disorders Seizures are one of the most unpredictable and frightening symptoms for people with epilepsy and other seizure disorders. But guess what? Medical marijuana can be a huge help!

Conditions 52

Conditions Chronic Pain Marijuana Treatment 52

Alchimia

JUNE 20, 2016

CBD is a cannabinoid present in cannabis plants with a very similar molecular structure to THC but without any kind of psychoactive effect. Indeed, CBD does not cause any effect on the user, no paranoia, euphoria or intoxication, which are usually associated with THC and the recreational use of marijuana.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” That is perhaps the biggest lie that is being perpetuated on the Alabama public today. ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). However, as the recent UNM study demonstrates, THC also boasts medicinal qualities and could be a more suitable choice for fast and effective nausea relief.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

JULY 24, 2019

It has been widely reported in the media that parents with children suffering from intractable epilepsy continue to experience difficulties in securing prescriptions for medical cannabis products containing THC. ” The Harley Street based clinic is the first of what will grow into a national network.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

JULY 7, 2022

filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. The prior art asserted was clinical literature involving administration of CBD or tetrahydrocannabinol (“THC”).

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105